Items tagged with Access

Response to TB treatment trials results published and presented during the 2022 Union World Conference on Lung Health (post with simple image)

Statement by Treatment Action Group (TAG) and the Global Tuberculosis Community Advisory Board (TB CAB)

New MSF report warns that major opportunity to increase access to newer, safer DR-TB drugs is at risk (post with simple image)

With newer TB drugs to go off patent in 2023, MSF calls on Johnson & Johnson, Otsuka, and TB Alliance to remove additional barriers blocking generic manufacturers from entering the market.

Page 74 of 74 · Total posts: 0

←First 73 74